Edition:
United States

Spero Therapeutics Inc (SPRO.OQ)

SPRO.OQ on NASDAQ Stock Exchange Global Select Market

12.91USD
20 Apr 2018
Change (% chg)

$-0.25 (-1.90%)
Prev Close
$13.16
Open
$13.11
Day's High
$13.14
Day's Low
$12.54
Volume
8,944
Avg. Vol
14,772
52-wk High
$19.00
52-wk Low
$9.66

Chart for

About

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing novel treatments for MDR bacterial infections. The Company is developing a portfolio of novel product candidates, including SPR994, Potentiator Platform (SPR741 and SPR206), and SPR720.... (more)

Overall

Beta: --
Market Cap(Mil.): $185.51
Shares Outstanding(Mil.): 14.37
Dividend: --
Yield (%): --

Financials

  SPRO.OQ Industry Sector
P/E (TTM): -- 188.22 33.60
EPS (TTM): -3.28 -- --
ROI: -- -0.74 13.19
ROE: -- -2.80 15.00

Earnings vs. Estimates